Teva Pharmaceutical Industries Limited (TEVA)

NYSE: TEVA · Real-Time Price · USD

41.85

-0.06 (-0.14%)

At close: Nov 4, 2026, 4:00 PM EST

41.70

-0.15 (-0.36%)

After-hours: Nov 4, 2026, 7:57 PM EST

Teva Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	48,832	32,824	20,990	9,663	9,929	9,541
Market Cap Growth	107.85%	56.38%	117.22%	-2.68%	4.07%	-7.39%
Enterprise Value	61,745	47,716	37,265	28,294	30,075	32,651
Last Close Price	41.85	28.61	18.50	8.62	8.94	8.65

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	98.04	23.28	-	-	-	22.88
PS Ratio	2.83	1.90	1.27	0.61	0.67	0.60
PB Ratio	6.12	4.15	3.67	1.19	1.16	0.85
P/FCF Ratio	39.54	28.59	28.02	11.48	9.53	40.43
P/OCF Ratio	27.59	19.91	16.83	7.06	6.25	11.96

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	3.58	2.77	2.25	1.79	2.02	2.06
EV/EBITDA Ratio	14.02	9.63	8.41	6.52	7.58	7.41
EV/EBIT Ratio	18.05	12.07	11.05	8.88	11.30	10.60
EV/FCF Ratio	50.00	41.56	49.75	33.60	28.86	138.35

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	2.13	2.18	3.18	2.50	2.52	2.10
Debt / EBITDA Ratio	3.75	3.39	3.98	4.53	5.26	5.19
Debt / FCF Ratio	13.76	15.01	24.28	24.08	20.80	99.97
Net Debt / Equity Ratio	1.62	1.73	2.60	2.10	2.19	1.91
Net Debt / EBITDA Ratio	2.93	2.76	3.36	3.93	4.75	4.86
Net Debt / FCF Ratio	10.46	11.91	19.87	20.25	18.11	90.80
Asset Turnover	0.43	0.43	0.40	0.36	0.33	0.32
Inventory Turnover	2.47	2.69	2.41	2.09	2.08	2.02
Quick Ratio	0.51	0.54	0.50	0.54	0.57	0.61
Current Ratio	0.95	1.04	0.98	1.02	1.05	1.14
Return on Equity (ROE)	6.65%	20.79%	-28.30%	-7.36%	-25.19%	4.09%
Return on Assets (ROA)	5.35%	6.17%	5.09%	4.55%	3.63%	3.91%
Return on Invested Capital (ROIC)	16.33%	18.73%	14.74%	12.10%	8.85%	6.18%
Return on Capital Employed (ROCE)	13.90%	14.50%	12.70%	10.20%	8.20%	8.40%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	1.02%	4.30%	-7.81%	-5.79%	-24.63%	4.37%
FCF Yield	2.53%	3.50%	3.57%	8.71%	10.49%	2.47%
Buyback Yield / Dilution	-2.12%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%
Total Shareholder Return	-2.12%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%

SEC Filings: 10-K · 10-Q